LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Strona główna・Stock List・NeoGenomics Inc

NeoGenomics Inc

Closed

8.96 -1.1

Buy Sell

Overview

Share price change

24h

Current

Min

8.67

Max

9.07

Key metrics
By Trading Economics
Income	-7.2M -17M
Sales	-3.5M 187M
EPS	0.01
Profit margin	-9.164
Employees	2,500
EBITDA	-5.8M -567K

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+64.72% upside

Dividends
By Dow Jones
Next Earnings	28 lip 2026

Market Stats
By TradingEconomics
Market Cap	51M 1.2B
Previous open	10.06
Previous close	8.96

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

7.7 / 10.27 Support & Resistance

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 maj 2026, 21:03 UTC

Earnings

Coinbase Global Swings to Loss Amid Softer Crypto Market

6 maj 2026, 18:06 UTC

Major Market Movers

Core Scientific Shares Rise on AI Data Center Expansion Plan

8 maj 2026, 17:04 UTC

Market Talk

Zcash Caps Off Parabolic Week -- Market Talk

8 maj 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 maj 2026, 15:20 UTC

Market Talk

'Altcoin Season' Indicator on the Rise -- Market Talk

8 maj 2026, 15:05 UTC

Market Talk

Bitcoin Slips Back Below the $80k Mark -- Market Talk

8 maj 2026, 12:19 UTC

Earnings

Bitcoin Price Dives Below $80,000. This Jobs Report Could End the Crypto Slump. -- Barrons.com

8 maj 2026, 10:55 UTC

Market Talk

Bitcoin Edges Higher as Risk Sentiment Improves Slightly -- Market Talk

8 maj 2026, 08:41 UTC

Earnings

Coinbase Misses Earnings and Revenue Estimates. The Stock Is Falling. -- Barrons.com

8 maj 2026, 06:25 UTC

Market Talk

Bitcoin Falls as U.S. and Iran Trade Attacks -- Market Talk

7 maj 2026, 21:25 UTC

Earnings

IREN 4Q Rev $144.80M >IREN

7 maj 2026, 20:22 UTC

Earnings

Coinbase Misses on Earnings and Revenue. The Stock Is Falling. -- Barrons.com

7 maj 2026, 14:30 UTC

Market Talk

Tokenized Assets Saw 22% Market Cap Jump in April -- Market Talk

7 maj 2026, 14:25 UTC

Market Talk

Stablecoin Market Cap Finds New High in April -- Market Talk

7 maj 2026, 11:43 UTC

Market Talk

Bitcoin's Rally Pauses as Investors Remain Cautious Over Iran War -- Market Talk

7 maj 2026, 07:00 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7 maj 2026, 07:00 UTC

Market Talk

Bitcoin Eases Slightly After Rally on Iran-U.S. Peace Deal Hopes -- Market Talk

7 maj 2026, 06:00 UTC

Earnings

Coinbase Heads Into Earnings Facing a Crypto Trading Slowdown -- Barrons.com

6 maj 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 maj 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 maj 2026, 18:46 UTC

Earnings

Acquisitions, Mergers, Takeovers

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 maj 2026, 17:10 UTC

Market Talk

Coinbase Perpetual Gold and Silver Futures Go Live -- Market Talk

6 maj 2026, 16:35 UTC

Market Talk

Major Crypto Assets Show Volatility as War-Ending Deal Mulled -- Market Talk

6 maj 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

6 maj 2026, 15:12 UTC

Market Talk

Strong Gains in Privacy Coins May Signal Developing Altcoin Demand -- Market Talk

6 maj 2026, 14:55 UTC

Market Talk

CME Launching Bitcoin Volatility Futures -- Market Talk

6 maj 2026, 14:11 UTC

Earnings

Acquisitions, Mergers, Takeovers

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 maj 2026, 13:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 maj 2026, 13:59 UTC

Market Talk

Cryptocurrency Breaks Out as Optimism Over War Grows -- Market Talk

6 maj 2026, 11:05 UTC

Earnings

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Rises Anyway. -- Barrons.com

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

64.72% upside

12 Months Forecast

Average 14.94 USD 64.72%

High 25 USD

Low 11 USD

Based on 12 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to NeoGenomics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.